Biocon , India's top listed biotech firm, plans to launch psoriasis drug Alzumab in the country in the July-September quarter, a top company executive said on Friday.
The company expects sales of 1 billion rupees from the drug over four years, Kiran Mazumdar-Shaw, chairman, Biocon said in a conference call.
Short Biocon, says Sukhani
Late on Thursday, Biocon reported an 8.24 percent rise in net profit to Rs 92 crore for the Oct-Dec quarter compared with a year earlier.
Anda sedang membaca artikel tentang
Biocon to launch new drug in July-Sept quarter
Dengan url
https://kesehatanda.blogspot.com/2013/01/biocon-to-launch-new-drug-in-july-sept.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Biocon to launch new drug in July-Sept quarter
namun jangan lupa untuk meletakkan link
Biocon to launch new drug in July-Sept quarter
sebagai sumbernya
0 komentar:
Posting Komentar